Literature DB >> 2090035

Effects of CBDP and MEPQ on the toxicity and distribution of [3H]-soman in mice.

S Shapira1, T Kadar, G Cohen, S Chapman, L Raveh.   

Abstract

Soman poisoning presents a problem in terms of its detailed pathophysiology and its detoxification mechanism(s). The present study was designed to evaluate the role of carboxylesterases (CaE) and cholinesterase (ChE) in the distribution and detoxification of soman in vivo. Mice were injected (i.v.) with 0.06-1.0 LD50 of [3H]-soman, 60 min following pretreatment with either 2-O-cresyl-4H-1:2:3 benzodioxa-phosphorine-2-oxide (CBDP), which blocks CaE or 7-(methylethoxyphosphinyloxy)-1-methyl quinolinium iodide (MEPQ), which selectively inhibits intravascular ChE. One hour after [3']-soman administration animals were sacrificed and whole body autoradiography was performed. High concentrations of [3H]-soman were found in lung and kidney in control mice, and low concentrations were found in central nervous system. Pretreatment with CBDP caused a 93% decrease in radioactive labelling in the lung, and a minor decrease in overall labelling, whereas pretreatment with MEPQ did not change the distribution pattern of [3H]-soman. It is concluded that lung is a major target organ for soman detoxification and that it exerts this effect by means of enzymatic reaction with soman through the abundant amounts of CaE which are present in the lung. Intravascular ChE has little (if any) effect on the distribution and detoxification of soman in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2090035     DOI: 10.1007/BF01974695

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  16 in total

1.  Tritium labeling of a powerful methylphosphonate inhibitor of cholinesterase: synthesis and biological applications.

Authors:  A Balan; I Barness; G Simon; D Levy; Y Ashani
Journal:  Anal Biochem       Date:  1988-02-15       Impact factor: 3.365

2.  A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations.

Authors:  C D Johnson; R L Russell
Journal:  Anal Biochem       Date:  1975-03       Impact factor: 3.365

3.  Xenobiotic accumulation and metabolism by isolated perfused rabbit lungs.

Authors:  T C Orton; M W Anderson; R D Pickett; T E Eling; J R Fouts
Journal:  J Pharmacol Exp Ther       Date:  1973-09       Impact factor: 4.030

4.  Metabolism of xenobiotics by the isolated perfused lung. Comparison with in vitro incubations.

Authors:  F C Law; T E Eling; J R Bend; J R Fouts
Journal:  Drug Metab Dispos       Date:  1974 Sep-Oct       Impact factor: 3.922

5.  Persistence of the anti-cholinesterase soman in rats; antagonism with a non-toxic simulator of this organophosphate.

Authors:  O L Wolthuis; H P Benschop; F Berends
Journal:  Eur J Pharmacol       Date:  1981-01-29       Impact factor: 4.432

6.  Factors modifying the toxicity of organophosphorous compounds including Soman and Sarin.

Authors:  F Fonnum; S H Sterri
Journal:  Fundam Appl Toxicol       Date:  1981 Mar-Apr

7.  The effect of carboxylesterase inhibition on interspecies differences in soman toxicity.

Authors:  D M Maxwell; K M Brecht; B L O'Neill
Journal:  Toxicol Lett       Date:  1987-11       Impact factor: 4.372

8.  Carboxylesterases, importance for detoxification of organophosphorus anticholinesterases and trichothecenes.

Authors:  F Fonnum; S H Sterri; P Aas; H Johnsen
Journal:  Fundam Appl Toxicol       Date:  1985-12

9.  The influence of 2-/o-cresyl/-4 H-1 : 3 : 2-benzodioxa-phosphorin-2-oxide (CBDP) on organophosphate poisoning and its therapy.

Authors:  B Bosković
Journal:  Arch Toxicol       Date:  1979-07-11       Impact factor: 5.153

10.  Distribution of 3H-soman in mice.

Authors:  T Kadar; L Raveh; G Cohen; N Oz; I Baranes; A Balan; Y Ashani; S Shapira
Journal:  Arch Toxicol       Date:  1985-10       Impact factor: 5.153

View more
  1 in total

Review 1.  Positron emission tomography studies of organophosphate chemical threats and oxime countermeasures.

Authors:  Charles M Thompson; John M Gerdes; Henry F VanBrocklin
Journal:  Neurobiol Dis       Date:  2019-04-22       Impact factor: 5.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.